HGHVX | THISX | HGHVX / THISX | |
Total Expense Ratio | 0.92 | 0.67 | 137% |
Annual Report Gross Expense Ratio | 0.92 | 0.67 | 137% |
Fund Existence | 7 years | 10 years | - |
Gain YTD | 4.308 | 6.963 | 62% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 500000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 788M | 11.4B | 7% |
Annual Yield % from dividends | 0.46 | 0.17 | 264% |
Returns for 1 year | -10.74 | -14.69 | 73% |
Returns for 3 years | 11.26 | -1.49 | -756% |
Returns for 5 years | -10.92 | -12.26 | 89% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HYBB | 47.04 | 0.05 | +0.11% |
iShares BB Rated Corporate Bond ETF | |||
BKEM | 73.83 | N/A | N/A |
BNY Mellon Emerging Markets Equity ETF | |||
CMCI | 25.45 | N/A | N/A |
VanEck® CMCI Commodity Strategy ETF | |||
SUSC | 23.70 | -0.02 | -0.11% |
iShares ESG USD Corporate Bond ETF | |||
ISMF | 26.78 | -0.10 | -0.36% |
iShares Managed Futures Active ETF |